InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Explore the detailed record of transactions filed by Cassella James V, Directeur du Développement. Insider active across 1 companies, notably Concert Pharmaceuticals, INC.. Aggregated, 7 reports have been published. Total volume traded: €72k. The latest transaction was disclosed on 14 February 2022 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€10,2283,762 shares@ €2.718914.3% of flow
Common Stock
SEC:0001209191-22-010072:0·
75,800 shares
Common Stock
SEC:0001209191-22-005876·
75,800 shares
Common Stock
SEC:0001209191-22-005876:0·
€8,1822,894 shares@ €2.827126.7% of flow
Common Stock
SEC:0001209191-22-002401·
€8,1822,894 shares@ €2.827111.4% of flow
Common Stock
SEC:0001209191-22-002401:0·
€22,5158,086 shares@ €2.784473.3% of flow
Common Stock
SEC:0001209191-21-051819·
€22,5158,086 shares@ €2.784431.4% of flow
Common Stock
SEC:0001209191-21-051819:0·
7 of 7 declarations
About Cassella James V
James V. Cassella is the Chief Development Officer of CONCERT PHARMACEUTICALS, INC. He oversees product development and research initiatives. James plays a key role in the innovation and growth strategy of the company.
